Systemic juvenile idiopathic arthritis: Diagnosis, management, and outcome

Nature Clinical Practice Rheumatology

Volumn 2, Issue 1, 2006, Pages 28-34

  Woo, Patricia ^a,b  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Biologics; Genetics; Prognosis; Systemic juvenile idiopathic arthritis

Indexed keywords

ATLIZUMAB; AZATHIOPRINE; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CHLORAMBUCIL; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN A; CYTOKINE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GOLD; GROWTH HORMONE; IMMUNOGLOBULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; METHOTREXATE; MIGRATION INHIBITION FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ANTIBODY; VITAMIN D;

AMYLOIDOSIS; AUTOINFLAMMATORY DISEASE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CAUCASIAN; CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL STUDY; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; DEFORMITY; DEVELOPMENTAL DISORDER; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE SEVERITY; EUROPE; GROWTH DISORDER; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LABORATORY TEST; MALIGNANT NEOPLASTIC DISEASE; MANAGED CARE; MORBIDITY; NORTH AMERICA; OCCUPATIONAL THERAPY; OSTEOPOROSIS; PATIENT EDUCATION; PATIENT SATISFACTION; PHYSIOTHERAPY; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RHEUMATIC FEVER; SARCOIDOSIS; SOCIAL ASPECT; TREATMENT OUTCOME; VASCULITIS;

EID: 31544465967     PISSN: 17458382     EISSN: 17458390     Source Type: Journal    
DOI: 10.1038/ncprheum0084     Document Type: Review

References (42)

1. Petty RE et al. (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: Second revision; Edmonton, 2001. J Rheumatol 31: 390-392
2. Symmons DP et al. (1996) Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register. J Rheumatol 23: 1975-1980
3. Fishman D et al. (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102: 1369-1376
4. Peterson LS et al. (1996) Juvenile rheumatoid arthritis in Rochester, Minnesota 1960-1993. Is the epidemiology changing? Arthritis Rheum 39: 1385-1390
5. Gare BA and Fasth A (1992) Epidemiology of juvenile chronic arthritis in southwestern Sweden: A 5-year prospective population study. Pediatrics 90: 950-958
6. Fujikawa S and Okuni M (1997) Clinical analysis of 570 cases with juvenile rheumatoid arthritis: Results of a nationwide retrospective survey in Japan. Acta Paediatr Jpn 39: 245-249
7. Seth V et al. (1996) Clinico -immunological profile in juvenile rheumatoid arthritis - an Indian experience. Indian J Pediatr 63: 293-300
8. Moroldo MB et al. (2004) Juvenile rheumatoid arthritis affected sibpairs: Extent of clinical phenotype concordance. Arthritis Rheum 50: 1928-1934
9. Thomson W et al. (2002) Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. Rheumatology (Oxford) 41: 1183-1189
10. Donn R et al. (2004) A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. Arthritis Rheum 50: 1604-1610
11. De Benedetti F et al. (2003) Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 48: 1398-1407
12. Ogilvie EM et al. (2003) The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: A multicenter study using simplex and multiplex juvenile idiopathic arthritis families. Arthritis Rheum 48: 3202-3206
13. Pascual V et al. (2005) Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 201: 1479-1486
14. Yokota S et al. (2005) Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 52: 818-825
15. Woo P et al. (2005) Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: Proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Res Ther 7: R1281-R1288
16. Wulffraat NM et al. (2005) Treatment of refractory autoimmune diseases with autologous stem cell transplantation: Focus on juvenile idiopathic arthritis. Bone Marrow Transplant 35 (Suppl 1): S27-S29
17. Villanueva J et al. (2005) Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther 7: R30-R37
18. Grom AA (2004) Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? Arthritis Rheum 50: 689-698
19. Ravelli A et al. (2005) Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr 146: 598-604
20. Woo P (2002) Cytokines and juvenile idiopathic arthritis. Curr Rheumatol Rep 4: 452-457
21. Mangge H et al. (1999) Long-term follow-up of cytokines and soluble cytokine receptors in peripheral blood of patients with juvenile rheumatoid arthritis. J Interferon Cytokine Res 19: 1005-1010
22. de Jager W et al. (2004) Simultaneous detection of 30 soluble mediators in plasma and synovial fluid of patients with JIA [abstract]. Clin Exp Rheumatol 22(4): 538
23. Silverman ED et al. (1990) Intravenous gamma globulin therapy in systemic juvenile rheumatoid arthritis. Arthritis Rheum 33: 1015-1022
24. Laxer RM and Schneider R (2004) Systemic-onset juvenile chronic arthritis. In Oxford Textbook of Rheumatology, 798-810 (Eds Isenberg DA et al.) Oxford: Oxford University Press
25. Woo P et al. (2000) Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum 43: 1849-1857
26. Kimura Y et al. (2005) Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis. J Rheumatol 32: 935-942
27. Wulffraat NM et al. (2003) Long-term follow-up of autologous stem cell transplantation for refractory juvenile idiopathic arthritis. Bone Marrow Transplant 32 (Suppl 1): S61-S64
28. Davies UM et al. (1994) Treatment of growth retardation in juvenile chronic arthritis with recombinant human growth hormone. J Rheumatol 21: 153-158
29. Fernandes JL et al. (2004) Biphosphonate-induced radiographic changes in two pediatric patients with rheumatic diseases. Skeletal Radiol 33: 732-736
30. White PH (2002) Transition: A future promise for children and adolescents with special health care needs and disabilities. Rheum Dis Clin North Am 28: 687-703
31. McDonagh JE et al. (2004) Unmet education and training needs of rheumatology health professionals in adolescent health and transitional care. Rheumatology (Oxford) 43: 737-743
32. Baum J et al. (1980) Juvenile rheumatoid arthritis. A comparison of patients from the USSR and USA. Arthritis Rheum 23: 977-984
33. Prieur AM et al. (1984) Prognosis of the systemic forms of juvenile chronic arthritis. Apropos of 100 cases. Arch Fr Pediatr 41: 91-97
34. Hafner R and Truckenbrodt H (1986) Course and prognosis of systemic juvenile chronic arthritis - retrospective study of 187 patients. Klin Padiatr 198: 401-407
35. Spiegel LR et al. (2000) Early predictors of poor functional outcome in systemic-onset juvenile rheumatoid arthritis: A multicenter cohort study. Arthritis Rheum 43: 2402-2409
36. Modesto C et al. (2001) Systemic onset juvenile chronic arthritis, polyarticular pattern and hip involvement as markers for a bad prognosis. Clin Exp Rheumatol 19: 211-217
37. Duffy CM (2004) Health outcomes in pediatric rheumatic diseases. Curr Opin Rheumatol 16: 102-108
38. Ansell BM and Hall MA (1976) Rheumatic disorders in childhood (1). Rep Rheum Dis 59: 1-2
39. Lomater C et al. (2000) Systemic onset juvenile idiopathic arthritis: A retrospective study of 80 consecutive patients followed for 10 years. J Rheumatol 27: 491-496
40. David J et al. (1994) The functional and psychological outcomes of juvenile chronic arthritis in young adulthood. Br J Rheumatol 33: 876-881
41. Packham JC and Hall MA (2002) Long-term follow-up of 246 adults with juvenile idiopathic arthritis: Education and employment. Rheumatology (Oxford) 41: 1436-1439
42. Packham JC and Hall MA (2002) Long-term follow-up of 246 adults with juvenile idiopathic arthritis: Social function, relationships and sexual activity. Rheumatology (Oxford) 41: 1440-1443